Laboratories and departments increasingly seek intellectual and scientific breakthroughs through diversification.
Research into clinical applications for prenatal gene therapy could offer hope to infants in the womb identified as developing grave conditions such as cystic fibrosis
Yale School of Engineering and Applied Science combines medicine, engineering, and problem-solving to increase the reliability of orthopaedic devices.
Joerg Bewersdorf has become an international expert in his own right in the field of super-resolution microscopy, which elevates the resolution of light microscopy to the scale of nanometers.
A class of biomaterials called bulk metallic glasses could transform future implanted medical devices and other engineered objects.
The line between mental illness and genius has long been known to be razor-thin. Yale researchers stumbled upon evidence of this fragile boundary while researching auditory hallucinations in schizophrenia.
Doctors and community advocates have worked together to combat the epidemic of substance use disorder.
Global warming, Jonathan Patz, MD, MPH, told an audience at internal medicine grand rounds in March, is real and it is affecting health around the world.
When two experts in their field get together and combine their labs, incredible things happen.
A new tool for gene editing offers new approaches to prevent disease.
A West Campus pioneer wonders why skin cancer doesn't spread in horses, cows, and pigs. The answer, surprisingly, relates to the evolution of mammalian pregnancy.
Clinicians at the Child Study Center worked with experts in genetics, neuroimaging, and eye tracking to understand what causes childhood disintegrative disorder, a rare form of autism.
Jesse Rinehart had a protein he wanted to fabricate in bacteria; Farren Isaacs had the perfect bacterial factory. They moved next door to each other, and the rest is history.
Ten years ago a campus was envisioned where researchers and scientists would share ideas and break new ground in medical research.
Exome sequencing allows scientists and clinicians to zero in on the mutations responsible for a disparate array of ailments.